UK markets closed

Y-mAbs Therapeutics, Inc. (YMAB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
15.29-0.05 (-0.33%)
At close: 04:00PM EDT
15.29 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts5465
Avg. Estimate-0.14-0.12-0.46-0.28
Low estimate-0.18-0.18-0.73-0.8
High estimate-0.11-0.08-0.340.02
Year ago EPS-0.15-0.14-0.49-0.46
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts4376
Avg. Estimate22.22M23.96M97.16M118.27M
Low estimate21.45M23.73M95.46M110.4M
High estimate23.23M24.4M99.6M133M
Year ago sales20.25M20.75M84.82M97.16M
Sales growth (year/est)9.70%15.50%14.50%21.70%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.32-0.24-0.19-0.2
Actual EPS-0.15-0.14-0.18-0.02
Difference0.170.10.010.18
Surprise %53.10%41.70%5.30%90.00%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate-0.14-0.12-0.46-0.28
7 days ago-0.14-0.12-0.46-0.34
30 days ago-0.14-0.12-0.46-0.34
60 days ago-0.2-0.22-0.78-0.89
90 days ago-0.2-0.22-0.71-0.83
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesYMABIndustrySector(s)S&P 500
Current qtr.6.70%N/AN/AN/A
Next qtr.14.30%N/AN/AN/A
Current year6.10%N/AN/AN/A
Next year39.10%N/AN/AN/A
Next 5 years (per annum)-88.60%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A